Natural killer cells and bone marrow transplantation

William J Murphy, Craig W. Reynolds, Pierre Tiberghien, Dan L. Longo

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Bone marrow transplantation is currently used in the treatment of a variety of neoplastic and nonneoplastic diseases. However, significant obstacles still limit the efficacy of this procedure. These include the occurrence of graft-versus-host disease, the failure of the marrow to engraft, the susceptibility of patients to opportunistic infections during the period of immunodeficiency after transplantation before full recovery of immune function, and finally, the recurrence of the cancer. Natural killer (NK) cells are lymphoid cells responsible for mediating a variety of immunologic and homeostatic functions. Initially described almost 20 years ago, the full range of functions carried out by these enigmatic cells continues to unfold. NK cells may be both beneficial and deleterious in bone marrow transplantation, depending on their genotype and activation status. Resting host-derived NK cells appear capable of mediating resistance to both autologous and allogeneic bone marrow cell grafts. At the other end of the spectrum, the transfer of activated NK cells of donor type appears to produce multiple beneficial effects during both syngeneic and allogeneic bone marrow transplantation. Here, we review and attempt to reconcile the literature concerning the basic biology of NK cells and their effects on hematopoiesis, both in vitro and in vivo. We also discuss the current issues in bone marrow transplantation and the potential role NK cells may play in determining the outcome of the marrow graft, the occurrence of graft-versus-host disease, and the generation of a graft-versus-tumor response when bone marrow transplantation is used for the treatment of cancer. [J Natl Cancer Inst 85:1475-1482, 1993].

Original languageEnglish (US)
Pages (from-to)1475-1482
Number of pages8
JournalJournal of the National Cancer Institute
Volume85
Issue number18
DOIs
StatePublished - Sep 15 1993
Externally publishedYes

Fingerprint

Transplantation
Bone Marrow Transplantation
Bone
Natural Killer Cells
Grafts
Cell
Graft vs Host Disease
Transplants
Neoplasms
Cancer
Bone Marrow
Transplantation (surgical)
Homologous Transplantation
Opportunistic Infections
Recovery of Function
Hematopoiesis
Bone Marrow Cells
Tumors
Chemical activation
Genotype

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging
  • Oncology
  • Cancer Research

Cite this

Natural killer cells and bone marrow transplantation. / Murphy, William J; Reynolds, Craig W.; Tiberghien, Pierre; Longo, Dan L.

In: Journal of the National Cancer Institute, Vol. 85, No. 18, 15.09.1993, p. 1475-1482.

Research output: Contribution to journalArticle

Murphy, William J ; Reynolds, Craig W. ; Tiberghien, Pierre ; Longo, Dan L. / Natural killer cells and bone marrow transplantation. In: Journal of the National Cancer Institute. 1993 ; Vol. 85, No. 18. pp. 1475-1482.
@article{67e858dd486348309e543416d0f6385f,
title = "Natural killer cells and bone marrow transplantation",
abstract = "Bone marrow transplantation is currently used in the treatment of a variety of neoplastic and nonneoplastic diseases. However, significant obstacles still limit the efficacy of this procedure. These include the occurrence of graft-versus-host disease, the failure of the marrow to engraft, the susceptibility of patients to opportunistic infections during the period of immunodeficiency after transplantation before full recovery of immune function, and finally, the recurrence of the cancer. Natural killer (NK) cells are lymphoid cells responsible for mediating a variety of immunologic and homeostatic functions. Initially described almost 20 years ago, the full range of functions carried out by these enigmatic cells continues to unfold. NK cells may be both beneficial and deleterious in bone marrow transplantation, depending on their genotype and activation status. Resting host-derived NK cells appear capable of mediating resistance to both autologous and allogeneic bone marrow cell grafts. At the other end of the spectrum, the transfer of activated NK cells of donor type appears to produce multiple beneficial effects during both syngeneic and allogeneic bone marrow transplantation. Here, we review and attempt to reconcile the literature concerning the basic biology of NK cells and their effects on hematopoiesis, both in vitro and in vivo. We also discuss the current issues in bone marrow transplantation and the potential role NK cells may play in determining the outcome of the marrow graft, the occurrence of graft-versus-host disease, and the generation of a graft-versus-tumor response when bone marrow transplantation is used for the treatment of cancer. [J Natl Cancer Inst 85:1475-1482, 1993].",
author = "Murphy, {William J} and Reynolds, {Craig W.} and Pierre Tiberghien and Longo, {Dan L.}",
year = "1993",
month = "9",
day = "15",
doi = "10.1093/jnci/85.18.1475",
language = "English (US)",
volume = "85",
pages = "1475--1482",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Natural killer cells and bone marrow transplantation

AU - Murphy, William J

AU - Reynolds, Craig W.

AU - Tiberghien, Pierre

AU - Longo, Dan L.

PY - 1993/9/15

Y1 - 1993/9/15

N2 - Bone marrow transplantation is currently used in the treatment of a variety of neoplastic and nonneoplastic diseases. However, significant obstacles still limit the efficacy of this procedure. These include the occurrence of graft-versus-host disease, the failure of the marrow to engraft, the susceptibility of patients to opportunistic infections during the period of immunodeficiency after transplantation before full recovery of immune function, and finally, the recurrence of the cancer. Natural killer (NK) cells are lymphoid cells responsible for mediating a variety of immunologic and homeostatic functions. Initially described almost 20 years ago, the full range of functions carried out by these enigmatic cells continues to unfold. NK cells may be both beneficial and deleterious in bone marrow transplantation, depending on their genotype and activation status. Resting host-derived NK cells appear capable of mediating resistance to both autologous and allogeneic bone marrow cell grafts. At the other end of the spectrum, the transfer of activated NK cells of donor type appears to produce multiple beneficial effects during both syngeneic and allogeneic bone marrow transplantation. Here, we review and attempt to reconcile the literature concerning the basic biology of NK cells and their effects on hematopoiesis, both in vitro and in vivo. We also discuss the current issues in bone marrow transplantation and the potential role NK cells may play in determining the outcome of the marrow graft, the occurrence of graft-versus-host disease, and the generation of a graft-versus-tumor response when bone marrow transplantation is used for the treatment of cancer. [J Natl Cancer Inst 85:1475-1482, 1993].

AB - Bone marrow transplantation is currently used in the treatment of a variety of neoplastic and nonneoplastic diseases. However, significant obstacles still limit the efficacy of this procedure. These include the occurrence of graft-versus-host disease, the failure of the marrow to engraft, the susceptibility of patients to opportunistic infections during the period of immunodeficiency after transplantation before full recovery of immune function, and finally, the recurrence of the cancer. Natural killer (NK) cells are lymphoid cells responsible for mediating a variety of immunologic and homeostatic functions. Initially described almost 20 years ago, the full range of functions carried out by these enigmatic cells continues to unfold. NK cells may be both beneficial and deleterious in bone marrow transplantation, depending on their genotype and activation status. Resting host-derived NK cells appear capable of mediating resistance to both autologous and allogeneic bone marrow cell grafts. At the other end of the spectrum, the transfer of activated NK cells of donor type appears to produce multiple beneficial effects during both syngeneic and allogeneic bone marrow transplantation. Here, we review and attempt to reconcile the literature concerning the basic biology of NK cells and their effects on hematopoiesis, both in vitro and in vivo. We also discuss the current issues in bone marrow transplantation and the potential role NK cells may play in determining the outcome of the marrow graft, the occurrence of graft-versus-host disease, and the generation of a graft-versus-tumor response when bone marrow transplantation is used for the treatment of cancer. [J Natl Cancer Inst 85:1475-1482, 1993].

UR - http://www.scopus.com/inward/record.url?scp=0027239889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027239889&partnerID=8YFLogxK

U2 - 10.1093/jnci/85.18.1475

DO - 10.1093/jnci/85.18.1475

M3 - Article

C2 - 8360930

AN - SCOPUS:0027239889

VL - 85

SP - 1475

EP - 1482

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 18

ER -